Abstract:
The importance and necessity of further research into this pathological syndrome are determined by the high incidence of chronic heart failure (CHF) in the population (1-2%), an increase in the average age of newly diagnosed patients, a progressive course, the need for inpatient treatment, and an unfavorable prognosis. This article discusses
new, effective directions for the pharmacological and non-drug correction of cardiac dysfunction in the treatment of CHF patients, numerous evolutionary changes in the heart failure problem, strategies for enhancing quality of life, and life expectancy for CHF patients.
